Published

TransMedics stock wins bullish view at Needham (NASDAQ:TMDX)

Summary by Seeking Alpha
TransMedics Group (TMDX) stock wins a Buy rating and a $208 target at Needham, on potential profits in 2024. Read more here.

0 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Right
100% Right
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)